Related Experiment Video
Updated: Jun 16, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Molecular MRI for sensitive and specific detection of lung metastases
Rosa T Branca1, Zackary I Cleveland, Boma Fubara
1Center for Molecular and Biomolecular Imaging, Department of Chemistry, Duke University, Durham, NC 27708, USA. tamara.branca@duke.edu
Abstract:
Early and specific detection of metastatic cancer cells in the lung (the most common organ targeted by metastases) could significantly improve cancer treatment outcomes. However, the most widespread lung imaging methods use ionizing radiation and have low sensitivity and/or low specificity for cancer cells. Here we address this problem with an imaging method to detect submillimeter-sized metastases with molecular specificity. Cancer cells are targeted by iron oxide nanoparticles functionalized with cancer-binding ligands, then imaged by high-resolution hyperpolarized (3)He MRI. We demonstrate in vivo detection of pulmonary micrometastates in mice injected with breast adenocarcinoma cells. The method not only holds promise for cancer imaging but more generally suggests a fundamentally unique approach to molecular imaging in the lungs.
Insights
This study introduces a novel lung imaging technique for early cancer detection. It uses targeted nanoparticles and hyperpolarized helium-3 MRI to identify tiny metastatic tumors with high molecular specificity.
Area of Science:
- Medical Imaging
- Oncology
- Nanotechnology
Background:
- Early detection of lung metastases is crucial for improving cancer treatment outcomes.
- Current lung imaging methods often lack sensitivity and specificity for detecting small cancer cells and use ionizing radiation.
- There is a need for advanced imaging techniques capable of molecularly specific detection of early-stage lung metastases.
Purpose of the Study:
- To develop and demonstrate a novel imaging method for the early and specific detection of submillimeter-sized lung metastases.
- To utilize iron oxide nanoparticles functionalized with cancer-binding ligands for targeted imaging.
- To employ high-resolution hyperpolarized (3)He MRI for enhanced sensitivity and specificity in detecting pulmonary micrometastases.
Main Methods:
- Functionalization of iron oxide nanoparticles with cancer-binding ligands to target metastatic cells.
- Administration of targeted nanoparticles to mice with induced lung micrometastases.
- High-resolution magnetic resonance imaging (MRI) using hyperpolarized (3)He gas to visualize targeted nanoparticles and detect metastases.
Main Results:
- Successful in vivo detection of submillimeter-sized pulmonary micrometastases in mice.
- Demonstration of molecular specificity in identifying cancer cells using the developed imaging approach.
- High-resolution imaging capability enabling visualization of small metastatic lesions.
Conclusions:
- The developed imaging method offers a promising approach for early and specific detection of lung metastases.
- This technique overcomes limitations of conventional imaging methods by providing molecular specificity without ionizing radiation.
- The approach has broader implications for molecular imaging in the lungs and potentially other organs.
Related Concept Videos
Magnetic Resonance Imaging
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
